Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02228798 · ClinicalTrials.gov registry record
Perioperative Anticoagulant Use for Surgery Evaluation Study
A clinical trial, sponsored by McMaster University.
- Completed
- Registry status
- 3,135
- Enrollment target
NCT02228798: Completed study, sponsored by McMaster University.
NCT02228798 is a clinical trial that has completed, run by McMaster University. The registered enrollment target is 3,135 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02228798 has completed, sponsored by McMaster University.
- COMPLETED
- Registry status
- 3,135 participants
- Enrollment target
Study Summary
The aim of the Perioperative Anticoagulant Use for Surgery Evaluation (PAUSE) Study, is to establish a safe, standardized protocol for the perioperative management of patients with atrial fibrillation (AF) who are receiving a novel oral anticoagulant (DOAC) drug, either dabigatran, rivaroxaban or apixaban, and require an elective surgery/procedure.
Primary Outcome
The first primary outcome is Major Bleed:Bleeding that is fatal or is symptomatic and retroperitoneal, intracranial, intraspinal, intraocular, pericardial, intramuscular with compartment syndrome, or intra-articular. Non-surgical bleeding causing a drop in hemoglobin greater than or equal to 20 g per L or leading to transfusion greater or equal to 2 units of blood within 24 hours.Surgical bleed that leads to intervention or interferes with mobilization or leads to delayed wound healing; or lead
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3,135 participants |
| Start Date | 2014-08-01 |
| Est. Completion | 2018-08-31 |
What the finished NCT02228798 record still lists
NCT02228798 is an observational study that tracks outcomes without assigning an intervention. Its 3,135 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 0 interventions.
NCT02228798 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02228798 about?
NCT02228798 is a clinical study titled "Perioperative Anticoagulant Use for Surgery Evaluation Study". The aim of the Perioperative Anticoagulant Use for Surgery Evaluation (PAUSE) Study, is to establish a safe, standardized protocol for the perioperative management of patients with atrial fibrillation (AF) who are receiving a novel oral anticoagulant (DOAC) drug, either dabigatran, rivaroxaban or ap...
What is the current status of trial NCT02228798?
This trial is currently completed. The enrollment target is 3,135 participants. The study started on 2014-08-01. Estimated completion is 2018-08-31.
Who is sponsoring clinical trial NCT02228798?
This trial is sponsored by McMaster University, which has 31 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06224205 · 3,150 participants · NA
Digital Detection of Dementia (D Cubed) Studies: D3
- NCT05051722 · 3,110 participants
Leveraging Methylated DNA Markers (MDMs) in the Detection of Endometrial Cancer, Ovarian Cancer, and Cervical Cancer
- NCT04722822 · 3,100 participants · NA
The HPV 9-10 Trial: Early Initiation of HPV Vaccination
- NCT05534243 · 3,090 participants · NA
The ED-AWARENESS-2 Trial
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI